| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate |
2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090107958-A |
| titleOfInvention |
Pharmaceutical preparations for the treatment of cardiovascular diseases |
| abstract |
The present invention provides a pharmaceutical formulation comprising a prior release compartment comprising olmesartan as a pharmacologically active ingredient, and a delayed release compartment comprising amlodipine as a pharmacologically active ingredient.n n n The pharmaceutical formulation of the present invention exhibits an even coercive action and prevents complications, and can maintain blood pressure evenly at the time of risk of complications, and is more useful for patients with hypertension with complications and patients requiring blood pressure suppression during sleep. . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160000957-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201005867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2883539-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2407159-A1 |
| priorityDate |
2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |